Netilmicin

Chemical formula: C₂₁H₄₁N₅O₇  Molecular mass: 475.587 g/mol  PubChem compound: 441306

Therapeutic indications

Netilmicin is indicated for:

Indication

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)

at least one of
Escherichia coli
Klebsiella
Enterobacter
Serratia
Citrobacter
Proteus mirabilis
Proteus vulgaris
Morganella morganii subsp morganii
Proteus penneri
Providencia rettgeri
Pseudomonas aeruginosa
Staphylococcus, coagulase negative
Methicillin resistant Staphylococcus
Staphylococcus aureus
Staphylococcus
and additionally at least one of
Respiratory tract infection
Infection of skin
Musculoskeletal infective disorder
Urinary tract infectious disease
Postoperative infection
Musculoskeletal infective disorder

Burn
Infection of gastrointestinal tract
Infectious disease of abdomen

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Escherichia coli
Klebsiella
Enterobacter
Serratia
Citrobacter
Proteus mirabilis
Proteus vulgaris
Morganella morganii subsp morganii
Proteus penneri
Providencia rettgeri
Pseudomonas aeruginosa
Staphylococcus, coagulase negative
Methicillin resistant Staphylococcus
Staphylococcus aureus
Staphylococcus
and additionally at least one of
Respiratory tract infection
Infection of skin
Musculoskeletal infective disorder
Urinary tract infectious disease
Postoperative infection
Musculoskeletal infective disorder

Burn
Infection of gastrointestinal tract
Infectious disease of abdomen

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only children (1 year - 12 years old)

at least one of
Escherichia coli
Klebsiella
Enterobacter
Serratia
Citrobacter
Proteus mirabilis
Proteus vulgaris
Morganella morganii subsp morganii
Proteus penneri
Providencia rettgeri
Pseudomonas aeruginosa
Staphylococcus, coagulase negative
Methicillin resistant Staphylococcus
Staphylococcus aureus
Staphylococcus
and additionally at least one of
Respiratory tract infection
Infection of skin
Musculoskeletal infective disorder
Urinary tract infectious disease
Postoperative infection
Musculoskeletal infective disorder

Burn
Infection of gastrointestinal tract
Infectious disease of abdomen

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈